52
Participants
Start Date
December 31, 2009
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Gadoxetic Acid Disodium (Eovist, BAY86-4873)
Participants have received Primovist/Eovist for liver Magnetic Resonance Imaging (MRI) as part of their routine care at participating institutions and additional diagnostic information are identified retrospectively from institution records
New York
Hershey
Durham
Cinncinati
Palo Alto
Many Locations
Many Locations
Many Locations
Many Locations
Lead Sponsor
Bayer
INDUSTRY